https://websites4-live-prod.ysmdevs.com/pathology/news-rss/?orgId=113871&title=Latest+News A selection of the latest research, academic, and other newsworthy developments at Tissue Services en-us Copyright 2026 Yale School of Medicine Thu, 14 May 2026 20:12:26 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/new-research-presented-from-yale-cancer-center-at-the-aacr-annual-meeting/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/new-research-presented-from-yale-cancer-center-at-the-aacr-annual-meeting/ Yale Cancer Center faculty and trainees joined over 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in San Diego for the 117th American Association for Cancer Research (AACR) annual meeting. Thu, 23 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/david-rimm-md-phd-chosen-for-pathology-cancer-research-award/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/david-rimm-md-phd-chosen-for-pathology-cancer-research-award/ The American Association for Cancer Researcher (AACR) named David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and of Medicine (Medical Oncology), as recipient of the 2026 James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research. Fri, 10 Apr 2026 14:15:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-research-advances-presented-at-san-antonio-breast-cancer-symposium-annual-meeting/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-research-advances-presented-at-san-antonio-breast-cancer-symposium-annual-meeting/ Members of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center attended the 48th annual San Antonio Breast Cancer Symposium (SABCS), from December 9-12, 2025. Sat, 13 Dec 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-to-present-breakthrough-breast-cancer-research-at-international-conference-in-texas/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-to-present-breakthrough-breast-cancer-research-at-international-conference-in-texas/ At SABCS, Yale Cancer Center experts will present groundbreaking research on hormone replacement therapy in breast cancer care, innovative treatment options for HER2-positive and hormone receptor-positive breast cancers, and the impact of patient-centered approaches to care. Mon, 01 Dec 2025 12:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/twenty-seven-ysm-faculty-members-recognized-for-highly-cited-research/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/twenty-seven-ysm-faculty-members-recognized-for-highly-cited-research/ Yale School of Medicine faculty members were recognized for publishing studies that rank in the top 1% based on the number of citations they received in their field. Wed, 12 Nov 2025 08:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/google-maps-approach-to-revolutionize-lung-cancer-treatment/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/google-maps-approach-to-revolutionize-lung-cancer-treatment/ Researchers, led by Thazin Nwe Aung, PhD, in the laboratory of David Rimm, MD, PhD, have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with the most common form of lung cancer to receive more effective individualized treatment. Fri, 10 Oct 2025 04:00:00 Z https://www.cancernetwork.com/view/exploring-the-next-frontier-of-cancer-biomarkers-in-precision-medicine https://www.cancernetwork.com/view/exploring-the-next-frontier-of-cancer-biomarkers-in-precision-medicine Regarding finding the right drug for the right patient, the reality of cancer management is far more complex than a single genetic mutation, according to David Rimm, MD, PhD. Fri, 03 Oct 2025 04:00:00 Z https://www.cancernetwork.com/view/looking-beyond-genomics-to-advance-precision-medicine-in-cancer-care https://www.cancernetwork.com/view/looking-beyond-genomics-to-advance-precision-medicine-in-cancer-care It may be time for precision medicine to expand beyond the genomics realm and enter the protein space in the management of melanoma and other cancers, according to David Rimm, MD, PhD. Fri, 03 Oct 2025 04:00:00 Z https://www.cancernetwork.com/view/advancing-ai-in-pathology-precision-medicine-and-the-melanoma-landscape https://www.cancernetwork.com/view/advancing-ai-in-pathology-precision-medicine-and-the-melanoma-landscape Dr. David Rimm spoke with Cancer Network on his latest research. Wed, 01 Oct 2025 04:00:00 Z https://www.wtnh.com/news/health/yale-cancer-center-researchers-using-ai-in-melanoma-research/ https://www.wtnh.com/news/health/yale-cancer-center-researchers-using-ai-in-melanoma-research/ David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and professor of medicine at Yale School of Medicine, discussed two important developments to come out of his lab. Mon, 25 Aug 2025 14:05:00 Z https://www.nbcconnecticut.com/video/news/local/could-ai-soon-help-people-with-cancer/3627558/ https://www.nbcconnecticut.com/video/news/local/could-ai-soon-help-people-with-cancer/3627558/ Yale Cancer Center researchers are trying to figure out if artificial intelligence can help people with cancer. They found that AI-based scoring of melanoma tumor-infiltrating immune cells, significantly outperforms traditional pathologist eyeballing. Wed, 20 Aug 2025 04:00:00 Z https://www.healio.com/news/hematology-oncology/20250804/assay-has-huge-potential-directing-antibodydrug-conjugate-treatment-for-breast-cancer https://www.healio.com/news/hematology-oncology/20250804/assay-has-huge-potential-directing-antibodydrug-conjugate-treatment-for-breast-cancer Yale Cancer Center researcher David Rimm, MD, PhD, who is the Anthony N. Brady Professor of Pathology, and colleagues developed a novel assay to measure HER2 and TROP2 levels in patients with breast cancer. These data could help physicians decide which antibody-drug conjugates should be used in each individual case. Mon, 04 Aug 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/personalized-medicine-advances-with-new-tool-to-guide-breast-cancer-treatment-choices/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/personalized-medicine-advances-with-new-tool-to-guide-breast-cancer-treatment-choices/ Yale pathology researchers created a dependable test that precisely measures key proteins found in breast cancer cells that can help oncologists choose the most effective targeted therapies for patients, says a report published July 16 in Precision Oncology, a journal of the American Society of Clinical Oncology. Wed, 16 Jul 2025 20:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/ai-outperforms-people-in-scoring-melanoma-tumor-infiltrating-immune-cells/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/ai-outperforms-people-in-scoring-melanoma-tumor-infiltrating-immune-cells/ A new Yale study found that open-source AI tools outperformed traditional, visual methods for measuring the abundance of melanoma biomarkers. Thu, 10 Jul 2025 15:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/pathology-laboratory-medicine-residents-fellows-feted-at-graduation-ceremony/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/pathology-laboratory-medicine-residents-fellows-feted-at-graduation-ceremony/ More than 100 people gathered June 10 to celebrate the accomplishments of graduating residents and fellows from the departments of pathology and laboratory medicine at Yale School of Medicine. Thu, 12 Jun 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/rimm-lab-marks-30-years-of-research-innovation-training-at-yale-pathology/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/rimm-lab-marks-30-years-of-research-innovation-training-at-yale-pathology/ The Rimm Lab at Yale Pathology, under the direction of David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and professor of medicine (medical oncology), marks 30 years of research, innovation, and training. Fri, 23 May 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/several-pathology-faculty-recognized-as-top-doctors-by-connecticut-magazine/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/several-pathology-faculty-recognized-as-top-doctors-by-connecticut-magazine/ Several Department of Pathology faculty members were among more than 100 Yale physicians recognized as top doctors in Connecticut by Connecticut Magazine in its annual Top Doctors issue. Wed, 21 May 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/new-research-presented-from-yale-cancer-center-at-aacr25/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/new-research-presented-from-yale-cancer-center-at-aacr25/ Yale Cancer Center faculty and trainees joined 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in Chicago for the 116th American Association for Cancer Research (AACR) annual meeting. Dr. Patricia LoRusso, Amy and Joseph Perella Professor of Medicine at Yale Cancer Center and AACR President for 2024-25, shared her global view on cancer. “Cancer is a global disease—it spares no continent, no country. And each patient that gets the disease deserves treatment.” Thu, 01 May 2025 12:00:00 Z https://www.nature.com/articles/s41571-024-00984-x https://www.nature.com/articles/s41571-024-00984-x Tumour-infiltrating lymphocytes (TILs) are crucial effectors of the anticancer immune response and are hypothesized to be key determinants the efficacy of immune-checkpoint inhibitors (ICIs). Herein, the authors review studies that have evaluated the roles of various TIL subsets as predictive biomarkers for ICIs, as well as opportunities, challenges and strategies for future research in this field. Fri, 17 Jan 2025 13:45:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-presents-advances-in-breast-cancer-at-the-san-antonio-breast-cancer-symposium/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-presents-advances-in-breast-cancer-at-the-san-antonio-breast-cancer-symposium/ Members of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center joined more than 11,000 physicians, scientists, and trainees focused on advancing research and clinical care in breast cancer attending the annual San Antonio Breast Cancer Symposium December 10-14, 2024. The Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers. Tue, 17 Dec 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/thazin-nwe-aung-phd-selected-for-patterson-mentored-research-award/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/thazin-nwe-aung-phd-selected-for-patterson-mentored-research-award/ Thazin Nwe Aung, PhD, Associate Research Scientist in Pathology, has been selected for a Patterson Mentored Research Award. Dr. Aung is a member of the Rimm Lab, and her mentor is David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and of Medicine (Medical Oncology). Fri, 06 Dec 2024 05:00:00 Z https://www.healio.com/news/hematology-oncology/20241111/more-sensitive-her2-test-may-allow-for-more-personalized-lung-cancer-therapy https://www.healio.com/news/hematology-oncology/20241111/more-sensitive-her2-test-may-allow-for-more-personalized-lung-cancer-therapy Researchers developed a highly sensitive, analytic, quantitative immunofluorescence assay that may enable more patients with lung cancer to benefit from an approved targeted therapy.The test measures HER2, a commonly used biomarker for breast cancer. Tue, 12 Nov 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/her2-and-lung-cancer-new-test-holds-great-promise-to-help-far-more-patients/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/her2-and-lung-cancer-new-test-holds-great-promise-to-help-far-more-patients/ A new, highly sensitive test for a cancer biomarker could allow more lung cancer patients to benefit from a recently FDA-approved chemotherapy. Thu, 26 Sep 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/immunotherapy-for-nsclc-potential-biomarkers-for-resistance-are-identified/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/immunotherapy-for-nsclc-potential-biomarkers-for-resistance-are-identified/ Two genes could serve as a screening mechanism for resistance to immunotherapy in non-small cell lung cancer (NSCLC), though further research is needed. Tue, 09 Jul 2024 16:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-study-finds-potential-in-predicting-immunotherapy-outcomes-in-patients-with-melanoma/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-study-finds-potential-in-predicting-immunotherapy-outcomes-in-patients-with-melanoma/ A recent study conducted by scientists at Yale Cancer Center demonstrates that spatial gene signatures can significantly enhance the prediction of immunotherapy outcomes in patients with melanoma. Wed, 26 Jun 2024 21:00:00 Z https://www.onclive.com/view/dr-rimm-on-unmet-needs-in-distinguishing-between-her2-low-and-her2-ultralow-breast-cancer https://www.onclive.com/view/dr-rimm-on-unmet-needs-in-distinguishing-between-her2-low-and-her2-ultralow-breast-cancer David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology, professor, medicine, Medical Oncology, Yale School of Medicine; director, Physician Scientist Training Program, Pathology Research, director, Tissue Microarray Facility, director, Yale Pathology Tissue Services, Pathology, Yale Cancer Center, discusses the primary challenges in distinguishing between HER2-low and HER2-ultralow breast cancer using current immunohistochemistry diagnostic kits. Wed, 26 Jun 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-pathology-faculty-members-recognized-as-top-doctors/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-pathology-faculty-members-recognized-as-top-doctors/ Several faculty members in the Department of Pathology at Yale School of Medicine have been recognized as among the Top Doctors in Connecticut. Wed, 01 May 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-faculty-and-trainees-present-at-aacr-annual-meeting/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-faculty-and-trainees-present-at-aacr-annual-meeting/ The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. Fri, 12 Apr 2024 04:00:00 Z https://medicine.yale.edu/ysm/news/yale-medicine-magazine/article/breast-cancer-research/ https://medicine.yale.edu/ysm/news/yale-medicine-magazine/article/breast-cancer-research/ Declines in the death rate for breast cancer have furthered overall progress in cancer mortality. Wed, 20 Mar 2024 04:00:00 Z https://www.hmpgloballearningnetwork.com/site/onc/conference-coverage/use-quantitative-multiplex-immunofluorescence-assay-detect-trop2-and https://www.hmpgloballearningnetwork.com/site/onc/conference-coverage/use-quantitative-multiplex-immunofluorescence-assay-detect-trop2-and David Rimm, MD, PhD, from Yale Cancer Center discussed new study results at SABCS which identified quantitative multiplex immunofluorescence assay as an optimal way to detect TROP2 and HER2 expression among patients with breast cancer. Fri, 05 Jan 2024 05:00:00 Z https://ascopost.com/news/december-2023/novel-selective-biomarker-may-help-select-effective-targeted-therapies-in-patients-with-metastatic-breast-cancer/ https://ascopost.com/news/december-2023/novel-selective-biomarker-may-help-select-effective-targeted-therapies-in-patients-with-metastatic-breast-cancer/ A novel selective biomarker (Troplex) may help select which antibody-drug conjugate therapy could be most effective in patients with metastatic breast cancer, according to findings presented at the 2023 San Antonio Breast Cancer Symposium. Thu, 07 Dec 2023 05:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/study-new-biomarker-tool-helps-select-targeted-therapies-to-treat-metastatic-breast-cancers/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/study-new-biomarker-tool-helps-select-targeted-therapies-to-treat-metastatic-breast-cancers/ A team of researchers led by senior author Dr. David Rimm and first author Charles “Jack” Robbins at Yale Cancer Center evaluated a new “selective” biomarker called Troplex™, which assesses HER2, TROP2, and cytokeratin using quantitative immunofluorescence. Mon, 04 Dec 2023 05:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/new-advanced-diagnostic-tests-lab-to-perform-interpret-clinical-grade-molecular-testing-of-biomarkers/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/new-advanced-diagnostic-tests-lab-to-perform-interpret-clinical-grade-molecular-testing-of-biomarkers/ The Yale Advanced Diagnostic Tests Laboratory in the Department of Pathology, a new unit of Yale Pathology Laboratories, offers access to novel molecular tests to external users, performing and interpreting clinical grade and high-quality molecular analysis of human tissue samples. Tue, 28 Nov 2023 18:30:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-researchers-awarded-2023-2024-grants-from-the-breast-cancer-research-foundation/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-researchers-awarded-2023-2024-grants-from-the-breast-cancer-research-foundation/ The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board and its Board of Directors recently announced its $60.2 million commitment to fund breast cancer research in 2023-2024, supporting more than 250 scientists at leading academic and medical institutions, including eight grants at Yale Cancer Center and Smilow Cancer Hospital. Thu, 12 Oct 2023 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/new-immunotherapy-treatment-brings-hope-to-patients-with-advanced-non-small-cell-lung-cancer/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/new-immunotherapy-treatment-brings-hope-to-patients-with-advanced-non-small-cell-lung-cancer/ The study's findings suggest that NC318, both alone and in combination with pembrolizumab, improved response rates and clinical outcomes for some patients with NSCLC. Fri, 08 Sep 2023 13:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/lung-adenocarcinomas-new-findings-about-resistance-to-targeted-therapies/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/lung-adenocarcinomas-new-findings-about-resistance-to-targeted-therapies/ A research team co-led by Dr. Katerina Politi found how mSWI/SNF complexes mediate resistance of lung adenocarcinomas to osimertinib and other tyrosine kinase inhibitors. Thu, 03 Aug 2023 15:00:00 Z https://www.medpagetoday.com/meetingcoverage/ascovideopearlsbreastca/104928 https://www.medpagetoday.com/meetingcoverage/ascovideopearlsbreastca/104928 David Rimm, MD, PhD, an Anthony N. Brady Professor of Pathology at Yale, discusses if pathologists are adequately quantifying the HER2 immunohistochemistry assay. Fri, 09 Jun 2023 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-and-smilow-cancer-hospital-physicians-and-scientists-presenting-latest-advances-at-2023-asco-annual-meeting/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-and-smilow-cancer-hospital-physicians-and-scientists-presenting-latest-advances-at-2023-asco-annual-meeting/ Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians will present new research at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 2nd to June 6th at McCormick Place in Chicago, Illinois. This year’s scientific program will feature more than 2,900 abstracts, covering all major diseases and research areas, including breast, lung, head and neck, gynecological, prostate, and gastric cancers. Thu, 18 May 2023 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/connecticut-magazines-2023-top-doctors-issue-recognizes-82-smilow-cancer-hospital-and-yale-cancer-center-physicians/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/connecticut-magazines-2023-top-doctors-issue-recognizes-82-smilow-cancer-hospital-and-yale-cancer-center-physicians/ Each year, Connecticut Magazine recognizes some of the state’s best physicians, who provide exceptional care for patients, with its annual “Top Doctors” issue. This year’s list includes 82 physicians from Smilow Cancer Hospital and Yale Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in the state. Mon, 01 May 2023 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/research-from-yale-pathology-highlights-the-challenges-of-interpreting-pd-l1-expression-with-cps-method/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/research-from-yale-pathology-highlights-the-challenges-of-interpreting-pd-l1-expression-with-cps-method/ Recent studies from Marie Robert, MD, and David Rimm, MD, PhD, highlight the challenges pathologists face when interpreting PD-L1 expression using the combined positive score method of interpretation of immunohistochemistry results for patients with gastric/gastroesophageal junction/esophageal cancers. Wed, 19 Apr 2023 04:00:00 Z https://www.onclive.com/view/dr-rimm-on-the-use-of-multiplex-spatial-proteomic-profiling-in-breast-cancer https://www.onclive.com/view/dr-rimm-on-the-use-of-multiplex-spatial-proteomic-profiling-in-breast-cancer David Rimm, MD, PhD, discusses both the use and advantages of utilizing multiplex spatial proteomic profiling in breast cancer. Tue, 14 Mar 2023 04:00:00 Z https://www.sabcsmeetingnews.org/spatial-and-single-cell-characterization-of-breast-cancer-progression-presenter-profile/ https://www.sabcsmeetingnews.org/spatial-and-single-cell-characterization-of-breast-cancer-progression-presenter-profile/ Presentation is about methods for assessment of multiple molecular variables on a single piece of tissue to better understand breast cancer (or really any cancer) with respect to progression or response or resistance to specific therapies. Wed, 07 Dec 2022 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-study-substantiates-impact-of-aducanumab-in-reducing-plaque-associated-with-alzheimers/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-study-substantiates-impact-of-aducanumab-in-reducing-plaque-associated-with-alzheimers/ Newly published research from Yale Pathology substantiates the impact of the drug aducanumab in reducing a plaque that is a defining pathologic feature of Alzheimer’s disease. Tue, 04 Oct 2022 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-researchers-awarded-grants-by-breast-cancer-research-foundation/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/yale-cancer-center-researchers-awarded-grants-by-breast-cancer-research-foundation/ The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board and its Board of Directors recently announced its 2022 research grants, including six funded grants at Yale Cancer Center and Smilow Cancer Hospital awarded to Mehra Golshan, MD, MBA, Melinda Irwin, PhD, MPH, Ian Krop, MD, PhD, Lajos Pusztai, MD, DPhil, David Rimm, MD, PhD, and Eric Winer, MD to support their research. Mon, 22 Aug 2022 04:00:00 Z https://websites4-live-prod.ysmdevs.com/pathology/news-article/rimm-lab-validates-objective-prognostic-marker-in-patients-with-early-stage-melanoma/ https://websites4-live-prod.ysmdevs.com/pathology/news-article/rimm-lab-validates-objective-prognostic-marker-in-patients-with-early-stage-melanoma/ An objective assessment of automated electronic tumor infiltrating lymphocytes percentage (eTILs%) scores is a strong prognostic marker in patients with early-stage melanoma. The study also identifies distinct TIL subpopulations that carry the prognostic values. Fri, 22 Jul 2022 04:00:00 Z